The risk of suicidality with selective serotonin reuptake inhibitors
Annals of the Academy of Medicine, Singapore
;
: 96-99, 2006.
Artículo
en Inglés
| WPRIM
| ID: wpr-300145
ABSTRACT
Antidepressants are efficacious in the treatment of depression but they are not without side effects. The recent findings on the risk of suicide with selective serotonin reuptake inhibitor treatment, however, have raised serious concerns about the risk-benefit ratio of their use. The development of the concerns is traced and the risks discussed, particularly in the child and adolescent group. The prescriber needs to be aware of the issues and of the need for close clinical monitoring of patients started on selective serotonin reuptake inhibitor treatment.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Suicidio
/
Factores de Edad
/
Inhibidores Selectivos de la Recaptación de Serotonina
/
Medición de Riesgo
/
Trastorno Depresivo Mayor
/
Diagnóstico
Tipo de estudio:
Estudio diagnóstico
/
Estudio de etiología
/
Factores de riesgo
Límite:
Adolescente
/
Adulto
/
Niño
/
Humanos
Idioma:
Inglés
Revista:
Annals of the Academy of Medicine, Singapore
Año:
2006
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS